Actively Recruiting
Led by Sohag University · Updated on 2025-02-11
40
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research investigates surgical removal of spontaneous intracerebral hemorrhage (ICH), a severe stroke type caused by bleeding into the brain tissue. ICH can cause brain injury from pressure effects and secondary cellular damage, with risks linked to high blood pressure and amyloid buildup in brain vessels. The study aims to assess the safety and effectiveness of surgery to remove the blood clot and prevent further brain injury, especially focusing on early intervention and modern minimally invasive techniques. Participants receive surgical evacuation of the intracerebral hematoma through craniotomy or minimally invasive methods. The surgery is intended to relieve pressure on brain tissue and reduce damage from blood products. Although surgery carries risks such as bleeding and infection, this trial evaluates outcomes after surgical removal of the hematoma, including clinical results and factors affecting prognosis. During the study, participants are monitored for morbidity and mortality at one and three months after surgery. Researchers assess clinical outcomes and complications, tracking recovery progress and survival rates. The total participation spans from surgery through follow-up visits to evaluate short- and medium-term effects of the surgical treatment on brain hemorrhage patients.
CONDITIONS
Surgical Evacuation Of Spontaneous Intracerebral Hematoma: Clinical Outcomes and Prognostic Factors
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several days post-surgery
Participants undergo surgical evacuation of intracerebral hemorrhage followed by immediate post-operative care to manage and monitor recovery.
1 surgery and immediate hospital stay
Duration - 3 months
Participants are monitored for morbidity and mortality outcomes after surgical evacuation of intracerebral hematoma.
Follow-up visits at 1 month and 3 months post-surgery
Total: 1 location
1
Sohag University hospitals
Sohag, Egypt
Actively Recruiting
M
Mohamed A Ragheb, Demonstrator
A
Ahmed S Mohamed, Professor
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Charlotte Jj van Asch, Merel Ja Luitse, Gabriël Je Rinkel...
https://pubmed.ncbi.nlm.nih.gov/20056489D Andrew Wilkinson, Aditya S Pandey, B Gregory Thompson...
https://pubmed.ncbi.nlm.nih.gov/28947377Judith M Wong, John E Ziewacz, Allen L Ho...
https://pubmed.ncbi.nlm.nih.gov/23116095